Skip to main content

News, Page 4

Large scale production of peptide program announced

March 4, 2021

Large scale production of peptide program announced

PeptiDream and YMC groups announce a formal joint-task group to scale successful lab work to multiple GMP production lines for specialty peptide drug products at the main factory of PeptiStar Inc. Learn More.
Webinar on Continuous Countercurrent Chromatography

February 9, 2021

Webinar on Continuous Countercurrent Chromatography

Twin-column continuous countercurrent chromatography is an excellent technique for achieving high yield and high purity in the manufacturing scale purification of peptide and oligo therapeutics.
Do You Have Questions About YMC America’s Move to Devens, MA?

February 8, 2021

Do You Have Questions About YMC America’s Move to Devens, MA?

As we announced in early January, effective February 1, YMC America business operations have relocated to Devens, MA. This move will enable us to add resources, space, and expanded services for our customers.  We invite you to read more about
YMC expands, consolidates operations in America

January 11, 2021

YMC expands, consolidates operations in America

YMC plans expansion of lab development services and consolidation of its Allentown, PA location into its larger Devens, MA facility. Learn More.
YMC America Business Operations to Relocate to Devens, MA

January 6, 2021

YMC America Business Operations to Relocate to Devens, MA

YMC America business operations will relocate to Devens, MA, to add resources, space, and improved access to the epicenter of the global bio/pharma industry.
The YMC Prep Story

December 21, 2020

The YMC Prep Story

Over the years, YMC success stories for Prep LC results have been told over and over again. We are proud of our end-to-end solutions for LC method development and scale-up.
Research lab celebrates by adding new continuous purification technology

December 3, 2020

Research lab celebrates by adding new continuous purification technology

Continuous chromatography technology or GMP scale added to major reseach facility duplicating capablity in USA. Patented MCSGP process significantly increase yield of oligo and peptide production. Learn More.
Thoughts for Thanksgiving

November 23, 2020

Thoughts for Thanksgiving

For many, the year 2020 has been a tough one. This Thanksgiving, we thought we would put products aside for a few seconds. The tradition of the Thanksgiving Season is that everyone should pause to take a moment to be
YMC-Triart Bio Phases are featured in a Q&A with LCGC magazine

October 28, 2020

YMC-Triart Bio Phases are featured in a Q&A with LCGC magazine

As a visitor to our website, you probably already know about YMC-Triart – our family of reversed-phase stationary phases based on a chemically and mechanically stable organic/inorganic hybrid silica.
YMC-Triart Prep Bio200 C8 for Peptide Purification

September 4, 2020

YMC-Triart Prep Bio200 C8 for Peptide Purification

There is a new YMC-Triart phase specifically designed for medium and large-scale purification of peptides. YMC-Triart Prep Bio200 C8 is an extension of the YMC-Triart product line that inherits the fundamental advantages of the YMC-Triart hybrid base particle.
Leading CMO purchases multiple GMP scale twin-column units

August 18, 2020

Leading CMO purchases multiple GMP scale twin-column units

Continuous chromatography technology now planned for production suites to give CMO a leading edge with new therapies at attractive cost point. Patented MCSGP will significantly increase yield of oligo and peptide production. Learn More.
FDA purchases YMC technology

July 14, 2020

FDA purchases YMC technology

FDA specifies bench top technology for study on continuous chromatography. Learn more.

Designed and developed by